Navigation Links
Children's Memorial Hospital of Chicago receives a grant from BioMarin to support adult PKU outreach
Date:7/21/2008

Chicago, IL, Children's Memorial Hospital of Chicago announced today that it has received a grant from BioMarin Pharmaceutical Inc. to support its Adult Phenylketonuria (PKU) Outreach Education Project. The goal of the program is to conduct outreach to PKU patients who are no longer being treated at PKU clinics to encourage them to return for further education about recent developments in the management and treatment of PKU.

"According to our records, approximately 250 PKU patients are not currently being seen in our clinic on a regular basis. This illustrates the magnitude of the problem and suggests that there may be as many patients currently outside the healthcare system as there are receiving care," said Barbara Burton, M.D., Director, PKU and Metabolic Disease Clinic, Children's Memorial Hospital, Chicago. "Untreated PKU can have severe neurological implications, including impaired cognitive function, mood disorders, mental illness and brain damage. Through specific targeting efforts, we hope to reach out to patients who are not receiving care to educate them about new options and advances in the treatment of PKU so that they can learn to manage and possibly avoid the severe neurological implications associated with untreated disease."

The goal of the project is to connect with each PKU and hyperphe patient not currently receiving care and encourage them to attend educational sessions arranged by Children's Memorial on the treatment of PKU and maternal PKU. The program will also identify additional outreach strategies that are most effective in reaching adult PKU patients who can benefit from new management guidelines and techniques.

"We are very pleased to provide this grant to Children's Memorial Hospital in support of this pilot program," said Steve Aselage, Senior Vice President of Global Commercial Development at BioMarin. "It's an important campaign and we applaud Dr. Burton and her team for proactively reaching out
'/>"/>

Contact: Julie Pesch
jpesch@childrensmemorial.org
773-880-3055
Children's Memorial Hospital
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
2. Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs
3. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
4. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
5. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
6. Nationwide Childrens Hospital involved in expanded access program for treatment of PKU
7. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
8. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
9. Childrens Hospital neurosurgeon receives grant
10. Pennsylvania Hospital recognized for excellence in bariatric surgery
11. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...duction method that begins by soaking corn kernels...s of ethanol and more usable co-products, giving e...about 20 percent. , "The conventional ethanol pr...stillers dried grains with soluble, it doesn,t hav...ois Agricultural Engineer Esha Khullar. "Whereas i...
(Date:11/9/2009)...ncer, the hopeful news is that pediatric survival ...e bad newstreatments that enable survival often ca...who have reached puberty currently have an opportu...g cancer treatment, they may have their semen froz...ever, do not produce sperm, although their testicu...
(Date:11/9/2009)...partment of Energy (DOE) has announced plans to fu...gham (UAB) School of Engineering on technologies t...ough the capture and permanent safe storage, or se...is in collaboration with Southern Company, the par...E through the 2009 American Recovery and Reinvestm...
Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 1Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 2Overexpressed protein converts noninvasive breast cancer into invasive disease 56431 3Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 1Global Network for Neglected Tropical Diseases Partners with IDB PAHO to Control and Eliminate Neglected Tropical Diseases in Latin America Caribbea 56430 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 1Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 2Kidz Med Inc Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season 56427 3
... 2008) -- On Nov. 8 and 9, Morgan Stanley Children...niversity Medical Center will host an "Innovations...att New York, which will feature lectures by inter...al research, genetic findings and stem cell therap... about congenital and primary immunodeficiencies; ...
...tudy led by investigators from Massachusetts Gener...look at how interactions between genes underlie a ...ory. Functional imaging studies reveal how a comb...ted with reduced activity of important brain struc...controls. The report has been released online in ...
...th expert Daniel Hayes, Ph.D., of the New York Cit... that a form of vitamin D could be one of our body... of radiation. Writing in the International Journ...ol, the active form of vitamin D, may protect us f...fe protective agent before or after a low-level nu...
Other Biology News:Innovations in Pediatric Medicine International Conference brings together pediatrics experts 2Interaction between gene variants may alter brain function in schizophrenia 2Could vitamin D save us from radiation? 2
(Date:11/9/2009)..., Nov. 9 CEL-SCI Corpora...enneth S. Rosenthal, Professor of Immunology and M...ege of Medicine and Pharmacy, reported on work con...veland Clinic and CEL-SCI on CEL-SCI,s LEAPS vacci...GTCbio Vaccine: "All Things Considered" Conference...
(Date:11/8/2009)... VIEW, Calif. Nov. 5, 2009 Complete Genomics, a ...today announced publication of a report in the jou...encing platform, including analysis of sequence da...les cost for these three genomes sequenced on the ...rom $8,005 for 87x coverage to $1,726 for 45x cove...
(Date:11/6/2009)...s., Nov. 6 Myriant Technologies LL... and manufacturer of renewable bio-chemicals, Uhd...ogy provider Uhde GmbH, one of the world,s leading...ed an alliance for the engineering, procurement &a...nic Acid plants based on renewable feedstocks. Th...
(Date:11/6/2009)...lif., Nov. 6 Intarcia Therapeutics...CA 650 (DUROS® continuous delivery of exenati...t the Ninth Annual Diabetes Technology Meeting in ...m.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ...ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces ...
Breaking Biology Technology:CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...healthcare giants, GE Healthcare and St. Jude Med...o develop a state-of-the-art cardiovascular ultras... disease. , ,Under terms of the agreement, the hea... integrated intracardiac echocardiography (ICE) im...s worldwide, enabling minimally invasive therapies...
...palities around the Midwest looking for new ways t...raditional approaches of bringing in developers to...thers are trying to entice businesses with tax inc...thin their municipalities. , ,This is a common pr...iving away tax incentives and adjusting building c...
...Wisconsin Angel Network , hoping to add another di...its new ePlan system to enable companies to use ri...r would-be investors. , ,The ePlan, which uses Med...d to help companies reach more investors with less...lane ticket, businesses seeking angel funding can ...
Other Biology Technology:GE, St. Jude to collaborate on visualization technology 2Electronic signs for municipalities: Las Vegas or lost revenues? 2Electronic signs for municipalities: Las Vegas or lost revenues? 3Electronic signs for municipalities: Las Vegas or lost revenues? 4Angel network introduces ePlan 2
Gold-plated 96-Well GeneAmp PCR System 9700 from Applied Biosystems
Rabbit Anti-ETR3 Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human ABCG2 Monoclonal Antibody, Unconjugated, Clone 5D3 from R&D Systems
...fied Formulation: 50mM Tris-HCl, pH 7.5, 0.1mM EGT...% 2-mercaptoethanol and 50% glycerol. Properites: ... enzyme Purification: DEAE-Sephadex, ammonium sulf... Superdex 200, and Mono Q chromatography to >95%. ...
Biology Products: